|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 胃癌预防亚太地区共识指南显示文摘背景与目的:胃癌是亚太地区的主要健康负担之一,但对其预防策略尚缺乏共识。本共识会议旨在评价预防胃癌的策略。方法:多学科专家组应用德尔菲(Delphi)法制订共识条文,提呈相关数据,对证据等级、推荐强度以及共识水平予以分级。结果:幽门螺杆菌(H.pylori)感染是非贲门胃腺癌必要但非充分的致病因子。盐的高摄入与胃癌强烈相关。新鲜果蔬对胃癌具有预防作用,但维生素和其他饮食补充并不能预防胃癌。H.pylori感染中的宿主-细菌相互作用导致不同类型的胃炎和胃酸分泌,从而决定疾病结局。胃癌阳性家族史是一个重要的危险因素。低血清胃蛋白酶原反映胃萎缩程度,可作为检出胃癌高危人群的标志物。H.pylori筛查和治疗被推荐作为减少高危人群胃癌危险性的一种策略,该策略在萎缩性胃炎发生前实施最为有效,但并不排除对胃癌高危人群的内镜监测。对胃癌低危人群不推荐行H.pylori筛查。H.pylori感染的一线治疗应遵循国家治疗指南。结论:高危人群中H.pylori筛查和根除策略可能会减少胃癌的发生率,本共识根据现有证据予以推荐。 | Kwong Ming Fock Nick Talley Paul Moayyedi Richard Hunt Takeshi Azuma Kentaro Sugano Shu Dong Xiao Shiu Kum Lam Khean Lee Goh Tsutomu Chiba Naomi Uemura Jae G Kim Nayoung Kim Tiing Leong Ang Varocha Mahachai Hazel Mitchell Abdul Aziz Rani Jyh Ming Liou Ratha-korn Vilaichone Jose Sollanor 钱本余 | 2008 | 胃肠病学2008，13，4： | 37 |
| 2 | Gastroenterologist perceptions of faecal microbiota transplantation显示文摘AIM: To explore gastroenterologist perceptions towards and experience with faecal microbiota transplantation(FMT).METHODS: A questionnaire survey consisting of 17 questions was created to assess gastroenterologists' attitude towards and experience with FMT. This was anonymously distributed in hard copy format amongst attendees at gastroenterology meetings in Australia between October 2013 and April 2014. Basic descriptive statistical analyses were performed.RESULTS: Fifty-two clinicians participated. Twenty one percent had previously referred patients for FMT,8% more than once. Ninety percent would refer patients with Clostridium difficile infection(CDI) for FMT if easily available,37% for ulcerative colitis,13% for Crohn's disease and 6% for irritable bowel syndrome. Six percent would not refer any indication,including recurrent CDI. Eighty-six percent would enroll patients in FMT clinical trials. Thirty-seven percent considered the optimal mode of FMT administration transcolonoscopic,17% nasoduodenal,13% enema and 8% oral capsule. The greatest concerns regarding FMT were: 42% lack of evidence,12% infection risk,10% non infectious adverse effects/lack of safety data,10% aesthetic,10% lack of efficacy,4% disease exacerbation,and 2% inappropriate use; 6% had no concerns. Seventy seven percent believed there is a lack of accessibility while 52% had an interest in learning how to provide FMT. Only 6% offered FMT at their institution.CONCLUSION: Despite general enthusiasm,most gastroenterologists have limited experience with,or access to,FMT. The greatest concerns were lack of supportive evidence and safety issues. However a significant proportion would refer indications other than CDI for FMT despite insufficient evidence. These data provide guidance on where education and training are required. | Sudarshan Paramsothy Alissa J Walsh Thomas Borody Douglas Samuel Johan van den Bogaerde Rupert WL Leong Susan Connor Watson Ng Hazel M Mitchell Nadeem O Kaakoush Michael A Kamm | 2015 | World Journal of Gastroenterology2015，21，38： | 5 |
| 3 | Protease-Activated Receptor-1 Down-regulates the Murine Inflammatory and Humoral Response to Helicobacter pylori显示文摘 | Janet L.K. Wee Yok–Teng Chionh Garrett Z. Ng Stacey N. Harbour Cody Allison Charles N. Pagel Eleanor J. Mackie Hazel M. Mitchell Richard L. Ferrero Philip Sutton | 2010 | Gastroenterology2010，，2： | 1 |
| 4 | Helicobacter pylori and bile reflux gastritis显示文摘 | Li Y Mitchell H Hazell S | 1991 | J Gastroenterol ttepatol1991，6，2： | 1 |
| 5 | Heli cobacter pylori and bile reflux gastritis 显示文摘 | Li YY Mitchell H Hazell S | 1991 | J Gastroenterol Hepatol1991，6，2： | 1 |
| 6 | Helicobacter pyloft and bile reflux gastritis显示文摘 | LI Y Y MITCHELL H HAZELL S | 1991 | J Gastroenterol Hepatol1991，6，2： | 1 |
| 7 | Wettability determination pore surface analysis显示文摘 | Mitchell A G Hazell L B Wellb K J | 1990 | Society of Petroleum Engineers1990，20，： | 1 |
| 8 | Helicobacter pylori and bile reflux gastritis显示文摘 | Mitchell H Hazell S | 1991 | J Gastreenterol Hepatol1991，6，2： | 1 |
| 9 | Helicobacter Pylori and Bile Reflux Gastritis显示文摘 | LIY Y MITCHELL H HAZELL S | 1991 | J Gastroenterl Hepatal1991，，： | 1 |
| 10 | Heli cobacter pylori and bile reflux gastritis显示文摘 | Li YY Mitchell H Hazell S | | 0，，2： | 1 |
| 11 | Microbial Dysbiosis in Pediatric Patients with Crohn’s Disease显示文摘 | Nadeem O. Kaakoush Andrew S. Day Karina D. Huinao Steven T. Leach Daniel A. Lemberg Scot E. Dowd Hazel M. Mitchell | 2012 | Journal of Clinical Microbiology2012，，10： | 1 |
| 12 | Helicobacter pylori and bile reflux gastritis 显示文摘 | Li YY Mitchell H Hazell S | 1991 | J Gastroenterol Hepatol1991，6，2： | 1 |
| 13 | Helicobacter pylori and bile reflux gastritis显示文摘 | Li YY Mitchell H Hazell S | 1991 | J Gastroenterol Hepatol1991，6，2： | 1 |
| 14 | Microbial Dysbiosis in Pediatric Patients with Crohn’s Disease显示文摘 | Nadeem O. Kaakoush Andrew S. Day Karina D. Huinao Steven T. Leach Daniel A. Lemberg Scot E. Dowd Hazel M. Mitchell | 2012 | Journal of Clinical Microbiology2012，，10： | 1 |
| 15 | Helicobacter pylori and bile reflux gastritis显示文摘 | Li YY Mitchell Hazell S | 1991 | J Gastroenterl Hepatol1991，6，12： | 1 |
| 16 | Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora显示文摘 | Martin J. Grehan Thomas Julius Borody Sharyn M. Leis Jordana Campbell Hazel Mitchell Antony Wettstein | 2010 | Journal of Clinical Gastroenterology2010，，8： | 1 |
| 17 | Helicobacter pylori and bile reflux gastritis显示文摘 | Li YY Mitchell H Hazell S | 1991 | J Gastroenterol Hepatol1991，6，2： | 1 |
| 18 | Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori 显示文摘 | MitcheLl HM Hazell SL Kolesnikow T | 1996 | Infect Immun1996，64，： | 1 |
| 19 | Helicobaeter Pylori and Bile Reflux Gastritis显示文摘 | Liy Y Mitchell H Hazell S | 1991 | J Gastroenterl Hepatal1991，27，： | 1 |
| 20 | Helicobacter pylori and bile reflux gastritis显示文摘 | Li YY Mitchell H Hazell S | 1991 | J Gastroenterol Hepatol1991，6，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员